Skip to main content
Premium Trial:

Request an Annual Quote

BioRegion Newsmakers: Mar 9, 2009

Premium

HCP Names Thomas Herzog as Executive Vice President/CFO as Mark Wallace Resigns

Thomas Herzog has been hired by publicly traded HCP as its executive vice president and chief financial officer effective May 1.

Herzog succeeds Mark Wallace, who held those positions as well as treasurer. Wallace will resign effective March 31, but "has agreed to serve in a consulting capacity until March 31, 2010, to assist in the transition" at the request of the board of directors, according to an HCP statement.

Herzog joins HCP from Apartment Investment and Management Company, known as Aimco, an S&P 500 real estate investment trust headquartered in Denver, where he most recently served as executive vice president and chief financial officer. Before that, Herzog worked at GE Real Estate, where he was chief accounting officer and global controller of a $30 billion real estate operation, and at the national office of Deloitte & Touche.

HCP is a real estate investment trust whose portfolio includes 104 life science properties.


Jack Schneider Joins Ezra Co. as Executive Managing Director

Jack Schneider has joined the Ezra Co. as executive managing director, where he will specialize in representing biotechnology companies and government contractors among tenants seeking build-to-suit transactions.

According to Ezra, Schneider has represented clients for more than 30 years and negotiated deals involving more than 9 million square feet.

Schneider, who previously worked at the commercial real estate brokerage Studley, earned a bachelors degree in history at the University of Maryland. He resides in Potomac, Md., with his wife and son.


Past Boston Patent Law Association President Leslie Meyer-Leon Joins Bromberg & Sunstein

Leslie Meyer-Leon has joined Bromberg & Sunstein, a Boston-based intellectual property law firm serving life sciences and technology clients, after managing her own law practice over the past eight years.

Meyer-Leon, the immediate past president of the Boston Patent Law Association, will assist clients in developing strategic patent portfolios especially in biotechnology, pharmaceuticals, biochemistry and immunology.

She received an associate's degree from Smith College, a doctorate from Boston College Law School, and a PhD in molecular and cellular biology from the University of Wisconsin-Madison.


Venable Elevates Intellectual Property Lawyer with Life-Sci Experience to Partner

David Farnum, an attorney with Venable LLP based in its Washington, DC, office, has been elected to partnership status at the law firm.

A member of Venable's intellectual property litigation group, Farnum focuses on intellectual property litigation, including patents, trade secrets and copyright. Farnum has litigated cases involving biotechnology, pharmaceuticals (including Hatch-Waxman litigation), medical devices, and other technologies.

Farnum received his JD degree from Yale University in 1998. He received his AB from the University of Chicago in 1992.


Palais des Congrès de Montréal Appoints Seven to Ambassadors' Club

The Palais des Congrès de Montréal will appoint two new members with life sciences backgrounds to its Ambassadors' Club at its March 11 Recognition Award Gala, which recognizes professionals who helped bring conventions to Montreal.

The two are Pierre Talbot, cited for bringing to Montreal the Meetings of the Three Divisions of the International Union of Microbiological Societies, set for July 2014; and Diego Mantovani, cited for the 10th World Biomaterials Congress, set for May 2016.

The Palais also marked 16 new conventions it secured for the city through 2016 — including one life-sci event, the 2009 World Congress on Industrial Biotechnology and Bioprocessing. All 16 conventions are projected to attract over 43,000 visitors to Montréal, and generate nearly CAN$95 million ($73.7 million) in economic spinoff activity.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.